Invexans Balance Sheet Health
Financial Health criteria checks 4/6
Invexans has a total shareholder equity of $1.6B and total debt of $550.6M, which brings its debt-to-equity ratio to 33.8%. Its total assets and total liabilities are $3.0B and $1.4B respectively. Invexans's EBIT is $86.8M making its interest coverage ratio 2.5. It has cash and short-term investments of $450.4M.
Key information
33.8%
Debt to equity ratio
US$550.60m
Debt
| Interest coverage ratio | 2.5x |
| Cash | US$450.42m |
| Equity | US$1.63b |
| Total liabilities | US$1.40b |
| Total assets | US$3.03b |
Recent financial health updates
Here's Why Invexans (SNSE:INVEXANS) Can Manage Its Debt Responsibly
Oct 30
We Think Invexans (SNSE:INVEXANS) Is Taking Some Risk With Its Debt
May 06Would Invexans (SNSE:INVEXANS) Be Better Off With Less Debt?
Dec 23
Recent updates
Invexans (SNSE:INVEXANS) Is Looking To Continue Growing Its Returns On Capital
Sep 23The Return Trends At Invexans (SNSE:INVEXANS) Look Promising
Apr 29Invexans (SNSE:INVEXANS) Is Doing The Right Things To Multiply Its Share Price
Aug 27Here's Why Invexans (SNSE:INVEXANS) Can Manage Its Debt Responsibly
Oct 30We Think Invexans (SNSE:INVEXANS) Is Taking Some Risk With Its Debt
May 06Invexans (SNSE:INVEXANS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 01Returns On Capital Are Showing Encouraging Signs At Invexans (SNSE:INVEXANS)
Mar 30Introducing Invexans (SNSE:INVEXANS), The Stock That Zoomed 155% In The Last Year
Feb 16Would Invexans (SNSE:INVEXANS) Be Better Off With Less Debt?
Dec 23Financial Position Analysis
Short Term Liabilities: INVEXANS's short term assets ($1.0B) exceed its short term liabilities ($830.5M).
Long Term Liabilities: INVEXANS's short term assets ($1.0B) exceed its long term liabilities ($569.1M).
Debt to Equity History and Analysis
Debt Level: INVEXANS's net debt to equity ratio (6.2%) is considered satisfactory.
Reducing Debt: INVEXANS's debt to equity ratio has increased from 2.1% to 33.8% over the past 5 years.
Debt Coverage: INVEXANS's debt is well covered by operating cash flow (26.4%).
Interest Coverage: INVEXANS's interest payments on its debt are not well covered by EBIT (2.5x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/23 14:47 |
| End of Day Share Price | 2023/11/21 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Invexans S.A. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Santander |